Antibodies to CCR2

Details for Australian Patent Application No. 2009283199 (hide)

Owner Pfizer Inc. Amgen Fremont, Inc.

Inventors Belouski, Shelley Sims; Green, Larry L.; Liang, Meina L.; Gladue, Ronald P.; Keller, Bradley T.; Ogawa, Shinji; Rajpal, Arvind; Tylaska, Laurie A.

Agent Cullens

Pub. Number AU-A-2009283199

PCT Pub. Number WO2010/021697

Priority 61/189,357 18.08.08 US

Filing date 17 August 2009

Wipo publication date 25 February 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C12N 5/12 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

Event Publications

24 March 2011 PCT application entered the National Phase

  PCT publication WO2010/021697 Priority application(s): WO2010/021697

16 June 2011 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Pfizer Inc.; Amgen Fremont, Inc., Application No. 2009283199, under INID (71) correct the name to Amgen Fremont Inc.; under INID (72) correct the co-inventor to Liang, Meina

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009283210-Fluoropolymer coated article

2009283197-Cervical occluder